“Glenmark partners with Pfizer to launch Abrocitinib in India”
Bengaluru, February 1, 2024: Pfizer and Glenmark Pharmaceuticals Ltd. (Glenmark) have joined hands to launch abrocitinib, a first-of-its-kind oral advanced systemic treatment for moderate-to-severe atopic dermatitis (AD), in India. Developed…